Pharming Group Nv Stock Probability of Future Pink Sheet Price Finishing Over 0.82

PHGUF Stock  USD 0.75  0.07  8.54%   
Pharming Group's future price is the expected price of Pharming Group instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Pharming Group NV performance during a given time horizon utilizing its historical volatility. Check out Pharming Group Backtesting, Pharming Group Valuation, Pharming Group Correlation, Pharming Group Hype Analysis, Pharming Group Volatility, Pharming Group History as well as Pharming Group Performance.
  
Please specify Pharming Group's target price for which you would like Pharming Group odds to be computed.

Pharming Group Target Price Odds to finish over 0.82

The tendency of Pharming Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 0.82  or more in 90 days
 0.75 90 days 0.82 
about 18.95
Based on a normal probability distribution, the odds of Pharming Group to move over $ 0.82  or more in 90 days from now is about 18.95 (This Pharming Group NV probability density function shows the probability of Pharming Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Pharming Group NV price to stay between its current price of $ 0.75  and $ 0.82  at the end of the 90-day period is about 69.0 .
Assuming the 90 days horizon Pharming Group has a beta of 0.39 indicating as returns on the market go up, Pharming Group average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Pharming Group NV will be expected to be much smaller as well. Additionally Pharming Group NV has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Pharming Group Price Density   
       Price  

Predictive Modules for Pharming Group

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharming Group NV. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pharming Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.040.753.05
Details
Intrinsic
Valuation
LowRealHigh
0.030.652.95
Details
Naive
Forecast
LowNextHigh
0.020.763.06
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.710.770.84
Details

Pharming Group Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Pharming Group is not an exception. The market had few large corrections towards the Pharming Group's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pharming Group NV, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pharming Group within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.19
β
Beta against Dow Jones0.39
σ
Overall volatility
0.03
Ir
Information ratio -0.11

Pharming Group Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharming Group for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharming Group NV can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Pharming Group NV generated a negative expected return over the last 90 days
Pharming Group NV has some characteristics of a very speculative penny stock

Pharming Group Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pharming Pink Sheet often depends not only on the future outlook of the current and potential Pharming Group's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharming Group's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding648.7 M

Pharming Group Technical Analysis

Pharming Group's future price can be derived by breaking down and analyzing its technical indicators over time. Pharming Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pharming Group NV. In general, you should focus on analyzing Pharming Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Pharming Group Predictive Forecast Models

Pharming Group's time-series forecasting models is one of many Pharming Group's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pharming Group's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Pharming Group NV

Checking the ongoing alerts about Pharming Group for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pharming Group NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Pharming Group NV generated a negative expected return over the last 90 days
Pharming Group NV has some characteristics of a very speculative penny stock

Additional Information and Resources on Investing in Pharming Pink Sheet

When determining whether Pharming Group NV is a strong investment it is important to analyze Pharming Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pharming Group's future performance. For an informed investment choice regarding Pharming Pink Sheet, refer to the following important reports:
Check out Pharming Group Backtesting, Pharming Group Valuation, Pharming Group Correlation, Pharming Group Hype Analysis, Pharming Group Volatility, Pharming Group History as well as Pharming Group Performance.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Please note, there is a significant difference between Pharming Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharming Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharming Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.